EPAS1 and non-small cell lung carcinoma: A strong association with HIF-2α overexpression and poor clinical outcomes such as OS (HR = 1.69, 95%CI: 1.39–2.06), DFS (HR = 1.87, 95%CI: 1.2–2.92), RPS (HR = 2.67, 95%CI: 1.32–5.38), and PFS (HR = 2.18, 95%CI: 1.25–3.78), including in NSCLC were reported.